In glioma tissues from the high-risk group of the training cohort, HOXA5, PTPN2, WT1, HOXD10, POSTN, ADAMDEC1 and MYBPH were highly expressed (Figure 5G). This evidence concerns the gene PTPN2 and central nervous system cancer.